Category: Neurology & Neurovascular
Exploring the Growth of the Neuromodulation Market: Key Drivers and Trends
Last year, more than 215,000 neuromodulation procedures were performed worldwide, with expectations that this number will climb to nearly 400,000 by 2029. Furthermore, it is expected that the market v... Read More
Tuesday Q&A: How Neuromodulation Devices are Performing in 2022
Neuromodulation devices are incredible devices that are used for regulating the nervous system to alleviate pain, or control the symptoms of Parkinson’s, urinary urge incontinence or gastroparesis, ... Read More
Top Trends per Segment in the U.S. Neurological Device Market
Neuromodulation, neurovascular, and neurosurgical devices collectively make up iData’s U.S. neurological devices market report. Within the United States, the overall neurological device market is gr... Read More
Medtronics Groundbreaking DTM™ Spinal Stimulation Used to Treat Chronic Pain
Medtronic recently announced the three-month results from a large, multicenter randomized controlled trial (RT) showing statistically significant and superior back pain relief through Differential Tar... Read More
BioSerenity Announces FDA Clearance for Electroencephalography (EEG) Wearable Device System
BioSerenity, Inc., recently announced they received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Neuronaute® Electroencephalography (EEG) System and IceCap® EEG wearable device t... Read More
LATEST!! Covid-19 Causes Major Impacts on Neurologic Disorders
The novel coronavirus (COVID-19; SARS-CoV-2) pandemic has affected millions worldwide. There are still many unknowns surrounding this virus yet one thing is for sure, in serious cases the virus causes... Read More
NeuroPace RNS System Received FDA Approval for MRI Labeling
NeuroPace RNS System for Epilepsy Received FDA Approval for MRI LabelingNeuroPace announced that its RNS® System has received FDA approval for MRI labeling, increasing number treatment options for ap... Read More
Abbott’s Low Dose Neuromodulation Implant for Chronic Pain
Abbott‘s Low-Dose Neuromodulation Implant for Chronic Pain, Proclaim XR, was recently featured at 2020 International CES. Proclaim XR can connect to Apple products via Bluetooth and to enables p... Read More
